Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats

A Correction to this paper has been published: https://doi.org/10.1007/s00213-021-05794-y

Saved in:
Bibliographic Details
Published in:Psychopharmacology 2021-04, Vol.238 (4), p.1227-1227
Main Authors: Levin, Edward D., Wells, Corinne, Hawkey, Andrew, Holloway, Zade, Blair, Graham, Vierling, Alexander, Ko, Ashley, Pace, Caroline, Modarres, John, McKinney, Anthony, Rezvani, Amir H., Rose, Jed E.
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Correction
Neurosciences
Pharmacology/Toxicology
Psychiatry
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1227
container_issue 4
container_start_page 1227
container_title Psychopharmacology
container_volume 238
creator Levin, Edward D.
Wells, Corinne
Hawkey, Andrew
Holloway, Zade
Blair, Graham
Vierling, Alexander
Ko, Ashley
Pace, Caroline
Modarres, John
McKinney, Anthony
Rezvani, Amir H.
Rose, Jed E.
description A Correction to this paper has been published: https://doi.org/10.1007/s00213-021-05794-y
doi_str_mv 10.1007/s00213-021-05794-y
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2487431973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A656116707</galeid><sourcerecordid>A656116707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282y-eabbad2467b96a5de55832dba21314234a3baf1688c38c7bcc2f6cd7a4cf06653</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoModlv9A15IwBsvOjXfmfVuWbQKBW_0OmQyJ23qTLImGcr-e7PdalHEhJzAyfO-nJOD0CtKLigh-l0hhFHetdARqdei2z9BKyo46xjR7ClaEcJ5x6nsT9BpKbekLdGL5-iEcykl7_UK3W1TzuBqSBHX9B5v5lCDt2OIcI4trjnsJsAZll213wGHeBOGUFM-b7lxcVBwgcl3dpxDDKVme--UPK43gNMu2HpQz8FDrDaGqTngBpUX6Jm3U4GXD_cZ-vbxw9ftp-7qy-Xn7eaqc6xn-w7sMNiRCaWHtbJyBCl7zsbBtsapYFxYPlhPVd873js9OMe8cqO2wnmilORn6O3Rd5fTjwVKNXMoDqbJRkhLMUz0WnC61ryhb_5Cb9OSY6vOMEkYaUetH6lrO4EJ0afWtDuYmo2SilKliW7UxT-otsf2Fy5F8KHl_xCwo8DlVEoGb3Y5zDbvDSXmMG1znLZpwdxP2-yb6PVDxcsww_hb8mu8DeBHoLSneA35saX_2P4EdyK1fQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2502050269</pqid></control><display><type>article</type><title>Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats</title><source>Springer Link</source><source>SPORTDiscus with Full Text</source><creator>Levin, Edward D. ; Wells, Corinne ; Hawkey, Andrew ; Holloway, Zade ; Blair, Graham ; Vierling, Alexander ; Ko, Ashley ; Pace, Caroline ; Modarres, John ; McKinney, Anthony ; Rezvani, Amir H. ; Rose, Jed E.</creator><creatorcontrib>Levin, Edward D. ; Wells, Corinne ; Hawkey, Andrew ; Holloway, Zade ; Blair, Graham ; Vierling, Alexander ; Ko, Ashley ; Pace, Caroline ; Modarres, John ; McKinney, Anthony ; Rezvani, Amir H. ; Rose, Jed E.</creatorcontrib><description>A Correction to this paper has been published: https://doi.org/10.1007/s00213-021-05794-y</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-021-05794-y</identifier><identifier>PMID: 33555387</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Correction ; Neurosciences ; Pharmacology/Toxicology ; Psychiatry</subject><ispartof>Psychopharmacology, 2021-04, Vol.238 (4), p.1227-1227</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>COPYRIGHT 2021 Springer</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33555387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Levin, Edward D.</creatorcontrib><creatorcontrib>Wells, Corinne</creatorcontrib><creatorcontrib>Hawkey, Andrew</creatorcontrib><creatorcontrib>Holloway, Zade</creatorcontrib><creatorcontrib>Blair, Graham</creatorcontrib><creatorcontrib>Vierling, Alexander</creatorcontrib><creatorcontrib>Ko, Ashley</creatorcontrib><creatorcontrib>Pace, Caroline</creatorcontrib><creatorcontrib>Modarres, John</creatorcontrib><creatorcontrib>McKinney, Anthony</creatorcontrib><creatorcontrib>Rezvani, Amir H.</creatorcontrib><creatorcontrib>Rose, Jed E.</creatorcontrib><title>Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats</title><title>Psychopharmacology</title><addtitle>Psychopharmacology</addtitle><addtitle>Psychopharmacology (Berl)</addtitle><description>A Correction to this paper has been published: https://doi.org/10.1007/s00213-021-05794-y</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Correction</subject><subject>Neurosciences</subject><subject>Pharmacology/Toxicology</subject><subject>Psychiatry</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kV1rFDEUhoModlv9A15IwBsvOjXfmfVuWbQKBW_0OmQyJ23qTLImGcr-e7PdalHEhJzAyfO-nJOD0CtKLigh-l0hhFHetdARqdei2z9BKyo46xjR7ClaEcJ5x6nsT9BpKbekLdGL5-iEcykl7_UK3W1TzuBqSBHX9B5v5lCDt2OIcI4trjnsJsAZll213wGHeBOGUFM-b7lxcVBwgcl3dpxDDKVme--UPK43gNMu2HpQz8FDrDaGqTngBpUX6Jm3U4GXD_cZ-vbxw9ftp-7qy-Xn7eaqc6xn-w7sMNiRCaWHtbJyBCl7zsbBtsapYFxYPlhPVd873js9OMe8cqO2wnmilORn6O3Rd5fTjwVKNXMoDqbJRkhLMUz0WnC61ryhb_5Cb9OSY6vOMEkYaUetH6lrO4EJ0afWtDuYmo2SilKliW7UxT-otsf2Fy5F8KHl_xCwo8DlVEoGb3Y5zDbvDSXmMG1znLZpwdxP2-yb6PVDxcsww_hb8mu8DeBHoLSneA35saX_2P4EdyK1fQ</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Levin, Edward D.</creator><creator>Wells, Corinne</creator><creator>Hawkey, Andrew</creator><creator>Holloway, Zade</creator><creator>Blair, Graham</creator><creator>Vierling, Alexander</creator><creator>Ko, Ashley</creator><creator>Pace, Caroline</creator><creator>Modarres, John</creator><creator>McKinney, Anthony</creator><creator>Rezvani, Amir H.</creator><creator>Rose, Jed E.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202104</creationdate><title>Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats</title><author>Levin, Edward D. ; Wells, Corinne ; Hawkey, Andrew ; Holloway, Zade ; Blair, Graham ; Vierling, Alexander ; Ko, Ashley ; Pace, Caroline ; Modarres, John ; McKinney, Anthony ; Rezvani, Amir H. ; Rose, Jed E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282y-eabbad2467b96a5de55832dba21314234a3baf1688c38c7bcc2f6cd7a4cf06653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Correction</topic><topic>Neurosciences</topic><topic>Pharmacology/Toxicology</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levin, Edward D.</creatorcontrib><creatorcontrib>Wells, Corinne</creatorcontrib><creatorcontrib>Hawkey, Andrew</creatorcontrib><creatorcontrib>Holloway, Zade</creatorcontrib><creatorcontrib>Blair, Graham</creatorcontrib><creatorcontrib>Vierling, Alexander</creatorcontrib><creatorcontrib>Ko, Ashley</creatorcontrib><creatorcontrib>Pace, Caroline</creatorcontrib><creatorcontrib>Modarres, John</creatorcontrib><creatorcontrib>McKinney, Anthony</creatorcontrib><creatorcontrib>Rezvani, Amir H.</creatorcontrib><creatorcontrib>Rose, Jed E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levin, Edward D.</au><au>Wells, Corinne</au><au>Hawkey, Andrew</au><au>Holloway, Zade</au><au>Blair, Graham</au><au>Vierling, Alexander</au><au>Ko, Ashley</au><au>Pace, Caroline</au><au>Modarres, John</au><au>McKinney, Anthony</au><au>Rezvani, Amir H.</au><au>Rose, Jed E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats</atitle><jtitle>Psychopharmacology</jtitle><stitle>Psychopharmacology</stitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2021-04</date><risdate>2021</risdate><volume>238</volume><issue>4</issue><spage>1227</spage><epage>1227</epage><pages>1227-1227</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><abstract>A Correction to this paper has been published: https://doi.org/10.1007/s00213-021-05794-y</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33555387</pmid><doi>10.1007/s00213-021-05794-y</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacology, 2021-04, Vol.238 (4), p.1227-1227
issn 0033-3158
1432-2072
language eng
recordid cdi_proquest_miscellaneous_2487431973
source Springer Link; SPORTDiscus with Full Text
subjects Biomedical and Life Sciences
Biomedicine
Correction
Neurosciences
Pharmacology/Toxicology
Psychiatry
title Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A17%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Amitifadine,%20a%20triple%20reuptake%20inhibitor,%20reduces%20self-administration%20of%20the%20opiate%20remifentanil%20in%20rats&rft.jtitle=Psychopharmacology&rft.au=Levin,%20Edward%20D.&rft.date=2021-04&rft.volume=238&rft.issue=4&rft.spage=1227&rft.epage=1227&rft.pages=1227-1227&rft.issn=0033-3158&rft.eissn=1432-2072&rft_id=info:doi/10.1007/s00213-021-05794-y&rft_dat=%3Cgale_proqu%3EA656116707%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282y-eabbad2467b96a5de55832dba21314234a3baf1688c38c7bcc2f6cd7a4cf06653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2502050269&rft_id=info:pmid/33555387&rft_galeid=A656116707&rfr_iscdi=true